Function: | Vitamins and Minerals Deficiency Drug |
---|---|
Certification: | GMP |
Grade Standard: | Medicine Grade |
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Cefotaxime sodium is a third-generation semi-synthetic cephalosporin, which is not as effective against gram-positive bacteria as cefazolin. Enterococci are resistant to this product, ineffective against penicillin-resistant pneumococci, and gram-negative. The bacteria have strong bactericidal activity, and the antibacterial effect on Escherichia coli, Bacillus influenzae, Pneumococcus, Proteus mirabilis, and Salmonella is stronger than that of cefoperazone, weak or resistant to Bacteroides fragilis, Pseudomonas aeruginosa, sewerage Enterobacteriaceae are not sensitive to this product.
Product Name | Pharmaceutical Chemicals Cefotaxime Sodium Sterile |
Appearance | white powder |
cas | 64485-93-4 |
Assay | 99% |
Keywords | Powder Cefotaxime Sodium;Raw Material Powder Cefotaxime Sodium;Pharmaceutical Cefotaxime Sodium |
Shelf Life | 24 months when properly stored |
Storage | Keep in a cool, dry, dark location |
It is not effective against penicillin-resistant pneumococci. It has a strong effect on Gram-negative bacteria. Bactericidal activity, antibacterial effect against Escherichia coli, influenza bacillus, Klebsiella pneumoniae, Proteus mirabilis, Salmonella is stronger than cefoperazone, weak or resistant to Bacteroides fragilis, Pseudomonas aeruginosa, Enterobacter cloacae Product is not sensitive.
In the treatment of lower respiratory tract infection, skin tissue, urinary tract infection, bone and joint infection and bacterial septicemia has achieved a good therapeutic effect.